Clinical Trial Update: Efficacy, Safety and Preference Study of a Insulin Pen PDS290 vs. a Novo Nordisk Marketed Insulin Pen in Diabetics [Phase 3]

View source ↗

Summary

Phase 3 trial comparing the PDS290 insulin pen to a Novo Nordisk marketed insulin pen in diabetics; results were posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Novo Nordisk marketed insulin pen
• PDS290 insulin pen (PDS290 insulin pen)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED | Results posted: 2017-03-27